ONTRUZANT
Marketedupdated 2mo agoby Samsung Bioepis Co Ltd
Approvedcommunity read0 votes
all catalysts(5)
approval · 5
Jan 18, 2019
approval
ONTRUZANT (TRASTUZUMAB-DTTB) — FDA approval
ONTRUZANT
→
Mar 19, 2020
approval
ONTRUZANT (TRASTUZUMAB-DTTB) — FDA approval
ONTRUZANT
→
Feb 28, 2025
approval
ONTRUZANT (TRASTUZUMAB-DTTB) — FDA approval
ONTRUZANT
→
Dec 5, 2025
approval
ONTRUZANT (TRASTUZUMAB-DTTB) — FDA approval
ONTRUZANT
→
Apr 15, 2026
approval
ONTRUZANT (TRASTUZUMAB-DTTB) — FDA approval
ONTRUZANT
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that